391 related articles for article (PubMed ID: 25816752)
1. DAMPs activating innate immune responses in sepsis.
Kang JW; Kim SJ; Cho HI; Lee SM
Ageing Res Rev; 2015 Nov; 24(Pt A):54-65. PubMed ID: 25816752
[TBL] [Abstract][Full Text] [Related]
2. Innate immune perturbations, accumulating DAMPs and inflammasome dysregulation: A ticking time bomb in ageing.
Kapetanovic R; Bokil NJ; Sweet MJ
Ageing Res Rev; 2015 Nov; 24(Pt A):40-53. PubMed ID: 25725308
[TBL] [Abstract][Full Text] [Related]
3. Microbial recognition and danger signals in sepsis and trauma.
Raymond SL; Holden DC; Mira JC; Stortz JA; Loftus TJ; Mohr AM; Moldawer LL; Moore FA; Larson SD; Efron PA
Biochim Biophys Acta Mol Basis Dis; 2017 Oct; 1863(10 Pt B):2564-2573. PubMed ID: 28115287
[TBL] [Abstract][Full Text] [Related]
4. Galectins in innate immunity: dual functions of host soluble beta-galactoside-binding lectins as damage-associated molecular patterns (DAMPs) and as receptors for pathogen-associated molecular patterns (PAMPs).
Sato S; St-Pierre C; Bhaumik P; Nieminen J
Immunol Rev; 2009 Jul; 230(1):172-87. PubMed ID: 19594636
[TBL] [Abstract][Full Text] [Related]
5. Host innate immune responses to microbial pathogens.
Delaloye J; Calandra T
Curr Vasc Pharmacol; 2013 Mar; 11(2):123-32. PubMed ID: 23506491
[TBL] [Abstract][Full Text] [Related]
6. Emerging role of innate immunity in organ transplantation part II: potential of damage-associated molecular patterns to generate immunostimulatory dendritic cells.
Land WG
Transplant Rev (Orlando); 2012 Apr; 26(2):73-87. PubMed ID: 22074784
[TBL] [Abstract][Full Text] [Related]
7. Innate immune memory: Implications for host responses to damage-associated molecular patterns.
Crișan TO; Netea MG; Joosten LA
Eur J Immunol; 2016 Apr; 46(4):817-28. PubMed ID: 26970440
[TBL] [Abstract][Full Text] [Related]
8. Host innate immune responses to sepsis.
Wiersinga WJ; Leopold SJ; Cranendonk DR; van der Poll T
Virulence; 2014 Jan; 5(1):36-44. PubMed ID: 23774844
[TBL] [Abstract][Full Text] [Related]
9. Role of high mobility group box 1 in inflammatory disease: focus on sepsis.
Bae JS
Arch Pharm Res; 2012 Sep; 35(9):1511-23. PubMed ID: 23054707
[TBL] [Abstract][Full Text] [Related]
10. Sensing Self and Non-Self DNA by Innate Immune Receptors and Their Signaling Pathways.
Sok SPM; Ori D; Nagoor NH; Kawai T
Crit Rev Immunol; 2018; 38(4):279-301. PubMed ID: 30806244
[TBL] [Abstract][Full Text] [Related]
11. Pattern recognition receptors: sentinels in innate immunity and targets of new vaccine adjuvants.
Olive C
Expert Rev Vaccines; 2012 Feb; 11(2):237-56. PubMed ID: 22309671
[TBL] [Abstract][Full Text] [Related]
12. Pattern Recognition Receptors and Control of Innate Immunity: Role of Nucleic Acids.
Fischer S
Curr Pharm Biotechnol; 2018; 19(15):1203-1209. PubMed ID: 30636600
[TBL] [Abstract][Full Text] [Related]
13. The role of innate immunity in septic acute kidney injuries.
Gonçalves GM; Zamboni DS; Câmara NO
Shock; 2010 Sep; 34 Suppl 1():22-6. PubMed ID: 20523275
[TBL] [Abstract][Full Text] [Related]
14. Danger-associated molecular patterns and inflammatory bowel disease: is there a connection?
Mueller C
Dig Dis; 2012; 30 Suppl 3():40-6. PubMed ID: 23295691
[TBL] [Abstract][Full Text] [Related]
15. Immunothrombotic Activity of Damage-Associated Molecular Patterns and Extracellular Vesicles in Secondary Organ Failure Induced by Trauma and Sterile Insults.
Eppensteiner J; Davis RP; Barbas AS; Kwun J; Lee J
Front Immunol; 2018; 9():190. PubMed ID: 29472928
[TBL] [Abstract][Full Text] [Related]
16. DANGER IN THE INTENSIVE CARE UNIT: DAMPS IN CRITICALLY ILL PATIENTS.
Timmermans K; Kox M; Scheffer GJ; Pickkers P
Shock; 2016 Feb; 45(2):108-16. PubMed ID: 26513703
[TBL] [Abstract][Full Text] [Related]
17. An ongoing search for potential targets and therapies for lethal sepsis.
Bao GQ; He L; Lee D; D'Angelo J; Wang HC
Mil Med Res; 2015; 2():20. PubMed ID: 26257917
[TBL] [Abstract][Full Text] [Related]
18. Danger signals activating innate immunity in graft-versus-host disease.
Zeiser R; Penack O; Holler E; Idzko M
J Mol Med (Berl); 2011 Sep; 89(9):833-45. PubMed ID: 21573893
[TBL] [Abstract][Full Text] [Related]
19. Regulating Immunity via ADP-Ribosylation: Therapeutic Implications and Beyond.
Kunze FA; Hottiger MO
Trends Immunol; 2019 Feb; 40(2):159-173. PubMed ID: 30658897
[TBL] [Abstract][Full Text] [Related]
20. Targeting damage-associated molecular pattern molecules (DAMPs) and DAMP receptors in melanoma.
Boone BA; Lotze MT
Methods Mol Biol; 2014; 1102():537-52. PubMed ID: 24258998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
